Wednesday, July 23, 2014
Partnership for Safe Medicines Conference C-SPAN Coverage Minimize

The Partnership for Safe Medicines held a forum on counterfeit prescription drugs.

Keynote Address:  Food and Drug Administration (FDA) Commissioner Margaret Hamburg gave her assessment of the problem of counterfeit drugs and talked about what the FDA is doing to combat it.

To view the keynote address 1 go to:
http://www.c-spanvideo.org/program/295894-4

 

Counterfeit Prescription Drugs:

Scott LaGanga opened the discussion with an overview of the issue. Other speakers included scholars, government officials, and an AIDS patient who accidentally used counterfeit drugs to treat his symptoms. Following their remarks, panelists responded to audience members' questions. Rick Roberts, patient/consumer Walt Bogdanich, New York Times Dr. Salvatore J. Giorgianni, Men's Health Network Marsha K. Millonig, American Pharmacists Association

To view the discussion of Panel go to:
http://www.c-spanvideo.org/program/295894-1

 

Counterfeit Drug Profits Part 1:

Panelists talked about who benefits from unsafe drugs. Topics included enforcement and prosecution efforts and difficulties, and the trafficking of controlled prescription drugs such as Oxycontin. This program was briefly interrupted by a pro forma Senate session and is continued in program identification number 295895-101. This program was part of a Partnership for Safe Medicines forum on counterfeit prescription drugs. 10:30a-12p Panel 2: Who's Benefiting from Unsafe Drugs? Moderator: Dr. Bryan Liang Charlie Cichon, National Association of Drug Diversion Investigators Nancy Kennedy, Food & Drug Administration, Office of Criminal Investigations Rob Hill, Drug Enforcement Agency Jeffrey Gren, U.S. Department of Commerce

To view the discussion of Panel go to:
http://www.c-spanvideo.org/program/295894-2

 

Counterfeit Drug Profits Part 2:

Who's Benefiting from Unsafe Drugs? Moderator: Dr. Bryan Liang Charlie Cichon, National Association of Drug Diversion Investigators Nancy Kennedy, Food & Drug Administration, Office of Criminal Investigations Rob Hill, Drug Enforcement Agency Jeffrey Gren, U.S. Department of Commerce

To view the discussion of panel go to:
http://www.c-spanvideo.org/program/295894-101

 

Anti-Counterfeit Drug Efforts:

Panelists talked about efforts and progress in fighting counterfeit drugs. This program was joined in progress. 1-2:30p Panel 3: Who's Making Progress Against Counterfeit Drugs? Moderator: Tom Kubic Dr. Michael Green, Centers for Disease Control and Prevention Hugo Bonar, Irish Medicines Board Richard Halverson, Immigration & Customs Enforcement, National Intellectual Property Rights Coordination Center John Gray, Healthcare Distribution Management Association.

To view the discussion of Panel go to:
http://www.c-spanvideo.org/program/295894-3

 

 

 

  

Enter Title Minimize
Hover here, then click toolbar to edit content
  

 

2009 © Rx-360